• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC

Catalog Number CLR222
Device Problems Incorrect, Inadequate or Imprecise Result or Readings (1535); Patient-Device Incompatibility (2682)
Patient Problems Wound Dehiscence (1154); Unspecified Infection (1930); No Code Available (3191)
Event Type  Injury  
Manufacturer Narrative
(b)(4). To date, the device has not been returned. If the product is returned for evaluation, any further information derived from the evaluation will be submitted in a supplemental 3500a form. Additional information was requested and the following was obtained: date the event occurred? n/k. Please confirm was is meant be insufficient closure? is this technique related or improper closure? technique related. Dr (b)(6) advised that there were a few factors that "has" contributed: prineo being removed too early by staff or moisture and rolled off (re-trained); insufficient closure leaving dead space (re-trained assistant). Is the wound dehiscence being attribute to the stratafix? no. Did the patient have any pre-existing health issues that could contribute to healing issues which could have contributed to the event? for example, medications, past reactions or allergies, weight, age, diabetes, obesity, etc? n/k. Did the patient fall or injury themselves in a way that may have affected the surgical area? no. Was the patient compliant with post-op instructions? n/k. What type of medical intervention was provided by the surgeon? what precisely was done as part of the intervention? re-closure. What is the patient¿s current condition? tba. How long post-op did the patient present with symptoms for each of the cases? approx 2 weeks. Has surgeon been trained on the product? yes. What is the procedure name and initial procedure date? spinal procedure. What date did the dehiscence occur on? about 2 weeks post-op. Was there any medical or surgical intervention performed (product removed; re-operation; re-closure; prescription steroids; antibiotics prescribed)? if so, please clarify. Re-closure. What is the most current patient status? n/k. Can you identify the product code and lot number of the product that was used? tba. Additional information was requested and the following was obtained: was there any alleged product deficiency relating to the prineo? reason that the prineo was accidently removed/ rolled off or removed? product code and lot number of prineo used? was there any stratafix suture deficiency (breakage) noted related to the wound dehiscence? please explain what layer experienced the wound dehiscence? was there any alleged product deficiency relating to the stratafix suture? will actual samples be returned for evaluation? will any unopened representative samples be returned for evaluation?.
Event Description
It was reported that a patient underwent a spinal procedure on an unknown date and topical skin adhesive was used. Approximately two weeks post op, the patient came back with wound dehiscence. The topical skin adhesive may have been removed accidently by agency staff at ward or rolled off due to moisture/sweat too early. The patient was resutured. The surgeon used barbed suture for fascia and muscle and another barbed suture for subcutaneous/subcuticular closure. The surgeon used topical skin adhesive on skin. The surgeon reports that the wound dehiscence is not attributed to the barbed suture. The surgeon opines that the dehiscence is technique related or possibly due to insufficient closure leaving dead space in the subcutaneous layer or the topical skin adhesive being taken off at wards before it's supposed to. The staff has been given thorough education. The surgeon has started to close fascia / muscle, subcutaneous and subcuticular with barbed suture. Additional information has been requested.
Manufacturer Narrative
Product complaint # (b)(4). Date sent to fda: 2/1/2019. Additional information was requested and the following was obtained: does the surgeon believe that any ethicon product (prineo/stratafix) contributed to the wound infection? no. The surgeon believes it was due to the insufficient closure due to technique that caused the wound infection. Initial procedure: hospital/date: (b)(6) 2018. Primary diagnosis: sacroiliac joint degeneration/left sacroiliac joint non-union. Procedure : l3-s1 & iliac fixation. L4/5/s1 sacroiliac joint posterolateral fusion. Implants: crunch, cement, infuse, atr set screws (lhc), signus offset connectors/screws. Wound closure: 1 stratafix/1 stratafix/2. 0 stratfix/prineo. Patient notes: (b)(6) 2018 : wound ooze. Microbiology from wound swab indicates moderate leucocytes & scanty gram positive cocci. (b)(6) 2018: mri lumbar spine- fluid collection. (b)(6) 2018: picc inserted for iv abs. Hospital/date: (b)(6) 2018 (current inpatient). Primary diagnosis: lumbar wound infection. Procedure 2: debride & re-suture lumbar wound. Wound closure:1 vicryl/1 vicryl/2. 0 vicryl/3. 0 nylon/ tension sutures. Antimicrobial therapy: ivabs. Patient notes: (b)(6) 2018: microbiology from wound swab indicates heavy growth of klebsiella oxtoca. Home with health choices & oral antibiotics. Follow-up appointments: (b)(6) 2018: practice nurse. (b)(6) 2019: dr. Co-morbidities: hypertension & obesity.
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Manufacturer (Section D)
p.o. box 151, route 22 west
somerville NJ 08876 0151
MDR Report Key8164609
MDR Text Key130358604
Report Number2210968-2018-77764
Device Sequence Number1
Product Code OMD
Combination Product (y/n)N
PMA/PMN Number
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 11/27/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/14/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator
Device Catalogue NumberCLR222
Was Device Available for Evaluation? No
Was the Report Sent to FDA?
Event Location No Information
Date Manufacturer Received11/27/2018
Is This a Reprocessed and Reused Single-Use Device?

Patient Treatment Data
Date Received: 12/14/2018 Patient Sequence Number: 1